SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Pharmaceutical Policy in Pakistan · Study

ChapterShelves

ChapterPharmaceutical Policy in Pakistan

Muhammad Atif2017

Chapter2017

Pharmaceutical Policy in Pakistan

Muhammad Atif · Mahmood Ahmad · Quratulain Saleem · Louise Elizabeth Curley · Muhammad Qamar-uz-Zaman · Zaheer‐Ud‐Din Babar

59 citations·0/0 files stored·Springer eBooks

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Systems and Reforms Pharmaceutical Quality and Counterfeiting

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 59 citations exist upstream.

References

2007The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries 2013Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns 2008An all time low budget for healthcare in Pakistan.

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2018Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistanarticle · 2 shared references 2016Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for accessarticle · 2 shared references 2011THE WORLD MEDICINES SITUATION 2011article · 1 shared reference 2015Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study dataarticle · 1 shared reference 2014Financial Risk Protection and Universal Health Coverage: Evidence and Measurement Challengesreview · 1 shared reference 2020The household economic burden of non-communicable diseases in 18 countriesarticle · 1 shared reference

Details

Year2017

Typechapter

Published2017-01-01

VenueSpringer eBooks

Languageen

Citations59

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1007/978-3-319-51673-8_3

openalex_workW2598098670

Links

Imported from OpenAlex (CC0) — nothing here is generated.